UBS Group’s Artivion AORT Stock Holding History
Bought
Maintained
Sold
Other funds holding AORT
UBS Group's AORT Position: Q3 2026 in Review
UBS Group reduced its Artivion (AORT) stake by 24% in Q3 2026, selling an estimated $2.82M and leaving 344,557 shares worth $7.86M. The position accounts for ﹤0.01% of the portfolio, ranked #3637.
UBS Group first reported a position in AORT in Q4 2014 and has held it in 48 quarters since. The position peaked at $12.8M in Q4 2025. 217 funds tracked by Wall St. Rank hold AORT as of Q3 2026.
- UBS Group held 344,557 shares of Artivion worth $7.86M as of Q3 2026.
- UBS Group sold 109,844 Artivion shares in Q3 2026, an estimated $2.82M.
- Artivion made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #3637 holding.
- UBS Group first reported a position in Artivion in Q4 2014 and has held it in 48 quarters since.
- UBS Group's Artivion position peaked at $12.8M in Q4 2025.
- 217 funds tracked by Wall St. Rank held Artivion as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.